Education
About Us
Working with TipRanks
Follow Us
GE Healthcare Technologies Inc (GEHC)
NASDAQ:GEHC
GEHC Stock Chart & Stats
$84.45
$3.08(3.69%)
At close: 4:00 PM EST
$84.45
$3.08(3.69%)
Day’s Range― - ―
52-Week Range$57.65 - $94.80
Previous CloseN/A
Volume1.76M
Average Volume (3M)3.86M
Market Cap
$38.25B
Enterprise Value$41.26B
Total Cash (Recent Filing)$4.00B
Total Debt (Recent Filing)$10.74B
Price to Earnings (P/E)17.4
Beta1.27
Next Earnings
Feb 02, 2026EPS Estimate
1.39Next Dividend Ex-DateN/A
Dividend Yield0.17%
Share Statistics
EPS (TTM)1.07
Shares Outstanding455,521,600
10 Day Avg. Volume3,333,582
30 Day Avg. Volume3,860,061
Financial Highlights & Ratios
PEG Ratio0.41
Price to Book (P/B)4.22
Price to Sales (P/S)1.81
P/FCF Ratio23.00
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue2.04
Enterprise Value/Gross Profit4.99
Enterprise Value/Ebitda10.86
Forecast
1Y Price Target
$89.08Price Target Upside5.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)4.55
Revenue Forecast (FY)$20.54B
Bulls Say, Bears Say
Bulls Say
Market ExpansionGEHC's decision to purchase Intelerad makes sense conceptually, strengthening the company's cloud-based and digital offerings.
Product InnovationGEHC's recent product launches, including photon-counting CT and full-body PET, are met with enthusiasm and seen as growth opportunities.
Strategic AcquisitionThe acquisition of Intelerad is expected to bolster GEHC's recurring revenue offerings and accelerate adoption of its AI algorithms within Imaging.
Bears Say
Competitive EnvironmentThe analyst maintains a neutral rating on GEHC given capex exposure and potential competition.
Earnings ImpactThe deal will be slightly dilutive to adjusted EPS in the short term, although management plans to offset this with cost efficiencies.
Stock PerformanceShares may trade down due to the higher price and dilutive nature of the deal.
GE Healthcare Technologies Inc News
GEHC FAQ
What was GE Healthcare Technologies Inc’s price range in the past 12 months?
GE Healthcare Technologies Inc lowest stock price was $57.65 and its highest was $94.80 in the past 12 months.
What is GE Healthcare Technologies Inc’s market cap?
GE Healthcare Technologies Inc’s market cap is $38.25B.
When is GE Healthcare Technologies Inc’s upcoming earnings report date?
GE Healthcare Technologies Inc’s upcoming earnings report date is Feb 02, 2026 which is in 47 days.
How were GE Healthcare Technologies Inc’s earnings last quarter?
GE Healthcare Technologies Inc released its earnings results on Oct 29, 2025. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.046 by $0.024.
Is GE Healthcare Technologies Inc overvalued?
According to Wall Street analysts GE Healthcare Technologies Inc’s price is currently Undervalued.
Does GE Healthcare Technologies Inc pay dividends?
GE Healthcare Technologies Inc pays a Quarterly dividend of $0.035 which represents an annual dividend yield of 0.17%. See more information on GE Healthcare Technologies Inc dividends here
What is GE Healthcare Technologies Inc’s EPS estimate?
GE Healthcare Technologies Inc’s EPS estimate is 1.39.
How many shares outstanding does GE Healthcare Technologies Inc have?
GE Healthcare Technologies Inc has 455,521,600 shares outstanding.
What happened to GE Healthcare Technologies Inc’s price movement after its last earnings report?
GE Healthcare Technologies Inc reported an EPS of $1.07 in its last earnings report, beating expectations of $1.046. Following the earnings report the stock price went down -2.544%.
Which hedge fund is a major shareholder of GE Healthcare Technologies Inc?
Currently, no hedge funds are holding shares in GEHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
GE Healthcare Technologies Inc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$89.08 (5.48% Upside)
$89.08 (5.48% Upside)
Blogger Sentiment
Bullish
GEHC Sentiment 85%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 3.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.5%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.32%
12-Months-Change
Fundamentals
Return on Equity
24.22%
Trailing 12-Months
Asset Growth
6.71%
Trailing 12-Months
Company Description
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc (GEHC) is a leading global provider of medical technologies and digital solutions, serving healthcare providers around the world. The company operates in various sectors, including imaging, monitoring, biomanufacturing, and digital solutions. GEHC's core products encompass advanced imaging systems such as MRI and CT scanners, ultrasound machines, and patient monitoring devices, as well as software solutions that enhance operational efficiency and patient care in healthcare facilities.
GEHC Company Deck
GEHC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance in revenue growth, strategic partnerships, and successful segments like Pharmaceutical Diagnostics. However, challenges such as tariffs impacting margins and issues in the Patient Care Solutions segment were noted. Despite these challenges, the company raised its adjusted EPS guidance, indicating a positive outlook.View all GEHC earnings summariesGEHC Revenue Breakdown
45.01% Imaging
26.08% AVS
15.89% PCS
12.75% PDx
0.26% Other
GEHC Stock 12 Month Forecast
Average Price Target
$89.08
▲(5.48% Upside)
Technical Analysis
Veeva Systems
―
Healthequity
―
Doximity
―
Tempus AI, Inc. Class A
―
Hinge Health, Inc. Class A
―
Ownership Overview
0.23% Insiders
30.84% Mutual Funds
28.97% Other Institutional Investors
9.96% Public Companies and Individual Investors